G42 Healthcare signs up with SomaLogic, to set up proteomics lab

G42 Healthcare signs up with SomaLogic, to set up proteomics lab

G42 Healthcare, a leading AI health-tech company, has signed a multiyear agreement with SomaLogic, a leading player in data-driven proteomics. As part of the agreement, G42 Healthcare will establish a proteomics laboratory in Masdar City Abu Dhabi, providing proteomic services to the UAE, Saudi Arabia, GCC and selected broader territories, G42 said in a statement.

The new G42 Healthcare proteomics laboratory will deliver testing for over 7,000 protein biomarkers using the SomaScan proteomics assay offering a brand-new service to life science, clinical research, clinical trials, pharma and healthcare providers in the region as a SomaLogic certified site. The lab, capable of delivering tens of thousands of analyses per year, will be set up adjacent to its global genomic sequencing hub – the Omics Centre of Excellence with a capacity to sequence 500,000 whole genomes annually.

The agreement includes the provision of testing for clinical environments via the SomaSignal test portfolio. These are advanced proteomic data-driven algorithms that can deliver meaningful clinical observations and prediction of risk across a multitude of conditions, including cardiovascular disease. The strategic agreement with SomaLogic comes close on the heels of G42 Healthcare’s recent partnership with AWS that enables quick and efficient omics data storage and transfer to